HDAC6 and amyotrophic lateral sclerosis: HDAC6 is thought to interact with polyubiquitin and have important roles in the aggresome-autophagy pathways, and proteosome formation [53], all of which are implicated in ALS disease pathogenesis, and therefore may be altered by ACY-738 administration [53].